Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type
PLoS Pathog
.
2020 Apr 28;16(4):e1008531.
doi: 10.1371/journal.ppat.1008531.
eCollection 2020 Apr.
Authors
Luca Schifanella
,
Susan W Barnett
,
Massimiliano Bissa
,
Veronica Galli
,
Melvin N Doster
,
Monica Vaccari
,
Georgia D Tomaras
,
Xiaoying Shen
,
Sanjay Phogat
,
Ranajit Pal
,
David C Montefiori
,
Celia C LaBranche
,
Mangala Rao
,
Hung V Trinh
,
Robyn Washington-Parks
,
Namal P M Liyanage
,
Giacomo Gorini
,
Dallas R Brown
,
Frank Liang
,
Karin Loré
,
David J Venzon
,
William Magnanelli
,
Michelle Metrinko
,
Josh Kramer
,
Matthew Breed
,
Galit Alter
,
Ruth M Ruprecht
,
Genoveffa Franchini
PMID:
32343743
PMCID:
PMC7188203
DOI:
10.1371/journal.ppat.1008531
Abstract
[This corrects the article DOI: 10.1371/journal.ppat.1008121.].
Publication types
Published Erratum